Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing
18/08/2026 22:15
BRIEF-TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing Aug 18 (Reuters) - Amgen Inc AMGN.O:
TSCAN THERAPEUTICS - AMGEN TO TERMINATE RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH TSCAN THERAPEUTICS - SEC FILING
TSCAN THERAPEUTICS - TERMINATION OF COLLABORATION AGREEMENT EFFECTIVE NOVEMBER 10, 2026 - SEC FILING
Source text: [ID:n0001193125-26-355664]
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amgen
See all newsUS RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Brief: Amgen Says Imdelltra Combo Reduced Risk Of Death By 58% In First-Line Lung Cancer
Corrected: Amgen drug combined with immunotherapy extends survival in lung cancer trial
US RESEARCH ROUNDUP- Amgen, Lockheed Martin, Norfolk Southern
Eli Lilly hits record high as healthcare stocks rally